Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewWe analyze the role of biotechnology in the program of the Spanish Presidency of the EU
From AseBio, we have analyzed the program of the Spanish Presidency and where R&D and biotechnology would be present, with the mission of identifying points on which we can have an impact and work
-
NewThe use of cell secretomes opens a new era of advanced therapies
The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st conference on the cellular secretome to highlight the potential of this pathway
-
-
EventBioPharm America™ 2023
-
-
NewPositive aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borde...
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the initial 167 randomized patients.
-
New#NewAlly | "AseBio is a bridge that allows us to connect with important sector leaders to ...
Meet Binit Tech, our new ally. We talked to Leandro Harillo, Technology Director.
-
New#NewMemberAseBio | 'AseBio is an excellent association that brings together the most impor...
Meet Zeta GmbH, our new member. We talked to Andreas Marchler, CEO of the company and with Christine Kolland, Business Development in Spain.
-
EventIRT
-
New#NewMemberAseBio | "AseBio is the collective voice of the biotechnology sector"
Meet Bexen Medical, our new member. We talked to Manuel Sánchez-Lagarejo, CEO of the company.
-
New#NewMemberAseBio | "AseBio is the major community of Spanish biotechnology that provides a...
Meet r Multipartner Virtual Data Room, our new member. We talked to María del Mar García, Area Manager Spain & LatAm at the company
-
New#BIOSPAIN2023Interview | "Biological therapies have become one of the main exponents of Pr...
Precision medicine has brought about a real revolution in the treatment of some diseases such as cancer. We analyze the latest advances from Promega, Silver Sponsor of BIOSPAIN 2023.
-
NewORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders
All resolutions were approved and 35% of the issued shares represented.
-
OfferTécnico/a de laboratorio
-
-
-
OfferDesarrollador/a web
-
OfferAnalista de datos
-
-
OfferTécnico/a
-